An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis
Resource Type
Information Statements, Practice Points
Year Published
2022
Related Resources
Scientific Societies Oppose Restrictions on Federal Research Grants
163 scientific societies letter opposing federal grant restrictions_06-18-2026
National Medical Organizations Applaud WISeR Amendment, Seek Reforms
Medical-Orgs-Applaud-WISeR-Amdt_Seek-Reforms_11-13-2025
Cases
PET Case: This is Why We Do Cardiac PET: Comparison of SPECT and PET in the Same Patient
Case summary: A 60-year-old patient with recurring exertional angina undergoes cardiac PET…
